National Cancer Institute, www.cancer.gov
The Nation's Progress in Cancer Research: An Annual Report for 2003
Back to Main Index
SPEEDING THE EVALUATION OF BIOMARKERS WITH TISSUE MICROARRAYS

Researchers need efficient, economical ways to analyze hundreds of tissue specimens to evaluate markers that will accurately predict a patient's prognosis and likely response to therapy. NCI's Cancer Diagnosis Program is working with clinical researchers around the world to make hundreds of specimens available on tissue microarrays.


Tissue microarrays are blocks of wax that contain large sets of tissue samples. Each block can contain hundreds of samples from different cancer cases - each just under a millimeter across. Tissue microarrays are designed to include enough samples of different tumors so that researchers can determine whether a particular marker is unique to a specific cancer site.

NCI is also creating tissue microarrays designed to give researchers enough statistical power to determine if specific markers change as the disease progresses. These arrays are specific to one type of cancer and contain tissue samples from patients diagnosed at different stages. Breast cancer tissue arrays are available from the NCI Cooperative Breast Cancer Tissue Resource.

NCI offers tissue microarrays for ovarian cancer, colon and rectal cancer, prostate cancer, and bladder cancer. The Cancer Diagnosis Program is working with NCI-supported Clinical Cooperative Groups to make arrays containing tissue samples from randomized clinical trials. Researchers will use these tissue microarrays to evaluate markers that can predict whether a patient is likely to respond to a particular therapy.


http://www.cancerdiagnosis.nci.nih.gov/

< Previous  |  Next >



National Cancer Institute Department of Health and Human Services National Institutes of Health FirstGov.gov